The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Helen L. Tremlett

Faculty of Medicine

Division of Neurology

Multiple Sclerosis Program

University of British Columbia

Canada

[email]@interchange.ubc.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Faculty of Medicine, Division of Neurology, Multiple Sclerosis Program, University of British Columbia, Canada. 2002 - 2010
  • Department of Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada. 2009
  • University of British Columbia, Department of Medicine, Division of Neurology, UBC Hospital, Canada. 2008
  • Division of Neurology, Department of Medicine, University of British Columbia, Vancouver Hospital and Health Sciences Center, Canada. 2003 - 2004
  • Department of Medicine (Neurology) rm S159, Vancouver Hospital and Health Sciences Centre, University of British Columbia, 2211 Wesbrook Mall, Canada. 2004

References

  1. New perspectives in the natural history of multiple sclerosis. Tremlett, H., Zhao, Y., Rieckmann, P., Hutchinson, M. Neurology (2010) [Pubmed]
  2. Impact of multiple sclerosis relapses on progression diminishes with time. Tremlett, H., Yousefi, M., Devonshire, V., Rieckmann, P., Zhao, Y. Neurology (2009) [Pubmed]
  3. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. Tremlett, H., Zhao, Y., Devonshire, V. J. Neurol. (2009) [Pubmed]
  4. Relapses in multiple sclerosis are age- and time-dependent. Tremlett, H., Zhao, Y., Joseph, J., Devonshire, V. J. Neurol. Neurosurg. Psychiatr. (2008) [Pubmed]
  5. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Tremlett, H., van der Mei, I.A., Pittas, F., Blizzard, L., Paley, G., Mesaros, D., Woodbaker, R., Nunez, M., Dwyer, T., Taylor, B.V., Ponsonby, A.L. Neuroepidemiology (2008) [Pubmed]
  6. Natural history of secondary-progressive multiple sclerosis. Tremlett, H., Yinshan Zhao, N., Devonshire, V. Mult. Scler. (2008) [Pubmed]
  7. Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses. Tremlett, H., Van der Mei, I., Pittas, F., Blizzard, L., Paley, G., Dwyer, T., Taylor, B., Ponsonby, A.L. Pharmacoepidemiol. Drug. Saf (2008) [Pubmed]
  8. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective. Tremlett, H.L., Oger, J. Mult. Scler. (2008) [Pubmed]
  9. Disability progression in multiple sclerosis is slower than previously reported. Tremlett, H., Paty, D., Devonshire, V. Neurology (2006) [Pubmed]
  10. Does the season or month of birth influence disease progression in multiple sclerosis?. Tremlett, H.L., Devonshire, V.A. Neuroepidemiology (2006) [Pubmed]
  11. Is late-onset multiple sclerosis associated with a worse outcome?. Tremlett, H., Devonshire, V. Neurology (2006) [Pubmed]
  12. Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients. Tremlett, H., Seemüller, S., Zhao, Y., Yoshida, E.M., Oger, J.D., Petkau, J. Neurology (2006) [Pubmed]
  13. The natural history of primary progressive MS in British Columbia, Canada. Tremlett, H., Paty, D., Devonshire, V. Neurology (2005) [Pubmed]
  14. Liver injury associated with the beta-interferons for MS: a comparison between the three products. Tremlett, H.L., Yoshida, E.M., Oger, J. Neurology (2004) [Pubmed]
  15. Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes. Tremlett, H.L., Oger, J. Mult. Scler. (2004) [Pubmed]
  16. Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis. Tremlett, H., Oger, J. J. Neurol. (2004) [Pubmed]
  17. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Tremlett, H.L., Oger, J. Neurology (2003) [Pubmed]
  18. Asthma and multiple sclerosis: an inverse association in a case-control general practice population. Tremlett, H.L., Evans, J., Wiles, C.M., Luscombe, D.K. QJM (2002) [Pubmed]
 
WikiGenes - Universities